GlassScriptPhysician profile
Richard Herman
NPI 1033558978
$3,319.30
in general payments reported to CMS, 2019-2025
21 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,067 · 2021: $44.33 · 2022: $1,587 · 2023: $85.69 · 2024: $431 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.96 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,348.00 | 2022 | |
| Wright Medical Technology, INC. | $737.79 | 2019 | |
| Trimed, INC. | $206.21 | 2019 | |
| Stryker Corporation | $168.97 | 2022-2024 | Iconix, Na |
| United Orthopedics LLC | $139.00 | 2022 | |
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Endo Pharmaceuticals INC. | $126.88 | 2021-2023 | Xiaflex |
| Endo USA, INC. | $101.84 | 2024-2025 | Xiaflex |
| Arthrosurface Incorporated | $76.99 | 2019 | |
| Horizon Therapeutics Plc | $46.52 | 2022-2023 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $31.87 | 2022-2024 | Iovera, Zilretta, Exparel |
| Davol INC. | $30.18 | 2025 | |
| Ethicon US, LLC | $29.11 | 2024 | Ethicon, Dermabond Prineo, Vistaseal |
| Bioventus LLC | $20.85 | 2025 | Durolane |
| Convatec INC. | $20.73 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.41 | 2019 | |
| Collegium Pharmaceutical, INC. | $18.06 | 2024 | Belbuca |
| Amgen INC. | $17.93 | 2024 | Krystexxa |
| Axogen | $16.40 | 2019 | |
| Heron Therapeutics, INC. | $14.86 | 2021 | |
| Pacira Therapeutics, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Herman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.